Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

NCT00531115 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
28
Enrollment
OTHER
Sponsor class

Stopped According to the study design, in the first step the number of responses was lower than the number required (\< 7).

Conditions

Interventions

Sponsor

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Collaborators